These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Kang M, Kim M, Choo MS, Bae J, Ku JH, Yoo C, Oh SJ. Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841 [Abstract] [Full Text] [Related]
24. [Insufficient detrusor contractility: a urodynamic and morphologic entity in prostatism]. Prieto Chaparro L, Salinas Casado J, Barba Solana C, Resel Estévez L. Arch Esp Urol; 1996 Sep; 49(7):727-39. PubMed ID: 9020009 [Abstract] [Full Text] [Related]
25. Bladder contractility and urethral resistance relation: what does a pressure flow study tell us? Sekido N. Int J Urol; 2012 Mar; 19(3):216-28. PubMed ID: 22233177 [Abstract] [Full Text] [Related]
26. Uroflowmetry and urodynamics. Kaplan SA, Te AE. Urol Clin North Am; 1995 May; 22(2):309-20. PubMed ID: 7539177 [Abstract] [Full Text] [Related]
27. [Qualitative grading of detrusor contractility in benign prostatic hyperplasia patients]. Liao L, Shi B, Liang C. Zhonghua Wai Ke Za Zhi; 1997 Mar; 35(3):173-5. PubMed ID: 10374527 [Abstract] [Full Text] [Related]
28. Clinical significance of urodynamic analysis in patients with benign prostatic enlargement complicated with diabetes mellitus. Zhang K, Xu Z, Zhang J, Wang H, Zhang D, Shi B. Urol Int; 2008 Mar; 81(2):149-52. PubMed ID: 18758211 [Abstract] [Full Text] [Related]
29. [Urethral resistance and bladder contractility]. Susset J. Ann Urol (Paris); 1993 Mar; 27(5):280-3. PubMed ID: 7508214 [Abstract] [Full Text] [Related]
30. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia. Kaplan SA. J Urol; 2005 Sep; 174(3):1010-1. PubMed ID: 16094029 [No Abstract] [Full Text] [Related]
31. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S. J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847 [Abstract] [Full Text] [Related]
32. The relaxant effect of ginseng saponin on the bladder and prostatic urethra: an in vitro and in vivo study. Jang HA, Cho S, Kang SG, Ko YH, Kang SH, Bae JH, Cheon J, Kim JJ, Lee JG. Urol Int; 2012 Mar; 88(4):463-9. PubMed ID: 22507987 [Abstract] [Full Text] [Related]
33. Change of external urethral sphincter function in prostatic patients. Yasuda K, Nagashima K, Murayama N, Yamanishi T, Tojo M, Shimazaki J. Urol Int; 1991 Mar; 47 Suppl 1():43-7. PubMed ID: 1719684 [Abstract] [Full Text] [Related]
34. Numerical investigation of urethra flow characteristics in benign prostatic hyperplasia. Jang KS, Kim JW, Ryu J. Comput Methods Programs Biomed; 2022 Sep; 224():106978. PubMed ID: 35797748 [Abstract] [Full Text] [Related]